Table 1 Characteristics of previously reported cases of listeriosis associated with alemtuzumab reported until February March 3, 2017
Source (reference) | Type of listeriosis | Gender | Indication | Number of infusions | Days from first infusion to onset | Outcome |
|---|---|---|---|---|---|---|
VigiBase 2017 (3) | Meningitis | Female | Multiple sclerosis | 5 | Unknown | Unknown |
VigiBase 2016 (3) | Meningitis | Female | Multiple sclerosis | 5 | 8 | Recovering |
VigiBase 2016 (3)a | Listeriosis | Male | Not reported | Unknown | Unknown | Died |
VigiBase 2016 (3) | Meningitis | Female | Multiple sclerosis | 3 | 5 | Recovered |
VigiBase 2016 (3) | Unknown | Female | Multiple sclerosis | 5 | 17 | Unknown |
VigiBase 2016 (3) | Unknown | Female | Multiple sclerosis | 5 | 23 | Unknown |
Sanofi Genzyme, data on file VigiBase 2016 (3) | Meningoencephalitis | Female | Multiple sclerosis | 5 | 7 | Died |
VigiBase 2016 (3) | Meningitis | Female | Multiple sclerosis | 5 | 17 | Recovered |
VigiBase 2016 (3) | Unknown | Female | Multiple sclerosis | 3 | 8 | Recovered |
VigiBase 2016 (3) | Unknown | Unknown | Multiple sclerosis | 5 | 9 | Unknown |
VigiBase 2016 (3) | Septicaemia | Female | Multiple sclerosis | Unknown | Unknown | Unknown |
VigiBase 2015 (3) | Unknown | Male | Multiple sclerosis | 5 | 9 | Recovered |
VigiBase 20 14 (3) | Meningitis | Female | Multiple sclerosis | 5 | 1 | Not recovered |
Rau 2015 (4) | Meningitis | Female | Multiple sclerosis | 5 | 6 | Recovered |
Rau 2015 (4) | Meningitis | Female | Multiple sclerosis | 5 | 8 | Recovered |
Wray 2009 (5) | Meningitis | Female | Multiple sclerosis | 3 | 19 | Recovered |
Ohm 2009 (6) | Sepsis | Female | Multiple sclerosis | 3 | 13 | Not recovered |
VigiBase 2010 | Meningitis | Male | Unknown | NA | Unknown | Not recovered |
VigiBase 2009 (3) | Unknown | Female | B cell lymphoma | NA | Unknown | Died |
VigiBase 2010 (3) | Sepsis | Male | Chronic lymphocytic leukemia | NA | Unknown | Unknown |
VigiBase 2011 | Unknown | Unknown | Chronic lymphocytic leukemia | NA | Unknown | Unknown |